SCHEMBL5433574

SCHEMBL5433574

CC(=O)OC(=O)CCN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28847637 0.97 ALDH1A1 (0.43)
Acetic Acid SCHEMBL27600268 0.95 ALDH1A1 (0.41)
SCHEMBL5813282 0.85 CYP1A2 (0.56)
SCHEMBL17433647 0.83 CYP1A2 (0.54)
SCHEMBL12538257 0.83 CYP1A2 (0.54)
SCHEMBL6048039 0.83 ALDH1A1 (0.50)
SCHEMBL35205 0.83 ALDH1A1 (0.56)
SCHEMBL284862 0.81 PAOX (0.58)
SCHEMBL19816433 0.81 PAOX (0.58)
SCHEMBL9170595 0.81 PAOX (0.58)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103508945-A Preparation method of 2-chloro-4-methyl nicotinonitrile BIOTALK CO LTD 2014-01-15 CN claimed
US-20250152533-A1 Novel Beta-Alanine Compositions and Methods of Use Thereof LEGACY CORPORATE LENDING, LLC, AS ADMINISTRATIVE AGENT 2025-05-15 US disclosed
WO-2017096260-A1 METHODS AND MATERIALS FOR PRODUCING 7-CARBON MONOMERS INVISTA NORTH AMERICA S.A.R.L. (US) 2017-06-08 WO disclosed
CN-103508945-A Preparation method of 2-chloro-4-methyl nicotinonitrile BIOTALK CO LTD 2014-01-15 CN disclosed
US-20130309282-A1 HAIRSTYLING AGENT COMPOSITION KIKUBOSHI CORPORATION (JP) 2013-11-21 US disclosed
US-20070141014-A1 Formulation assistants MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) 2007-06-21 US disclosed
CN-1874991-A Compounds capable of binding to the S1P receptor and pharmaceutical uses thereof ONO PHARMACEUTICAL CO (JP) 2006-12-06 CN disclosed
EP-1218354-A1 QUINAZOLINE DERIVATIVES AND THEIR USE AS PHARMACEUTICALS AstraZeneca AB (SE) 2002-07-03 EP disclosed
US-6303317-B1 PREFERENTIAL AMINO ACID SEQUENCE PROBE; FOR AS A DIAGNOSTIC DETECTION TOOL THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2001-10-16 US disclosed
EP-1091945-A1 CYCLIC CARBAMATES AND ISOXAZOLIDINES AS IIB/IIIA ANTAGONISTS Du Pont Pharmaceuticals Company (US) 2001-04-18 EP disclosed
WO-2001021596-A1 QUINAZOLINE DERIVATIVES AND THEIR USE AS PHARMACEUTICALS ASTRAZENECA AB (SE) 2001-03-29 WO disclosed
WO-2000000481-A1 CYCLIC CARBAMATES AND ISOXAZOLIDINES AS IIB/IIIA ANTAGONISTS DU PONT PHARMACEUTICALS COMPANY (US) 2000-01-06 WO disclosed
WO-1998032848-A9 PEPTIDE PROBES TO COIL PROTEINS AND METHODS FOR MAKING THE SAME 1998-11-26 WO disclosed
WO-1998032848-A1 PEPTIDE PROBES TO COIL PROTEINS AND METHODS FOR MAKING THE SAME THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1998-07-30 WO disclosed